-->

Iklan Billboard 970x250

Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet
»

Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet

Ajstyles
0
Covaxin, the homegrown coronavirus vaccine that was authorized for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has...
Baca Juga
SHARE
Subscribe to get free updates

Related Posts

Post a Comment

Post a Comment

Iklan Tengah Post